Literature DB >> 17900205

Augmentation strategies to increase antidepressant efficacy.

Richard C Shelton1.   

Abstract

Augmentation strategies for the treatment of major depressive disorder (MDD) are needed when patients with MDD have not tolerated or responded to antidepressant monotherapies. Clinicians can employ sequenced treatment steps, preferably coupled with the use of a treatment algorithm, to utilize augmentation strategies that will enable patients to achieve remission. The focus of augmentation therapy has been combining an antidepressant medication with another antidepressant; however, atypical antipsychotics are becoming commonly used to augment antidepressants. Beyond antidepressants and antipsychotics, alternative augmentation strategies include emerging pharmacologic treatments and nonpharmacologic strategies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900205

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  2 in total

Review 1.  5-HT(1A) receptor function in major depressive disorder.

Authors:  Jonathan Savitz; Irwin Lucki; Wayne C Drevets
Journal:  Prog Neurobiol       Date:  2009-02-07       Impact factor: 11.685

2.  Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.

Authors:  Graham J Emslie; Taryn Mayes; Giovanna Porta; Benedetto Vitiello; Greg Clarke; Karen Dineen Wagner; Joan Rosenbaum Asarnow; Anthony Spirito; Boris Birmaher; Neal Ryan; Betsy Kennard; Lynn DeBar; James McCracken; Michael Strober; Matthew Onorato; Jamie Zelazny; Marty Keller; Satish Iyengar; David Brent
Journal:  Am J Psychiatry       Date:  2010-05-17       Impact factor: 18.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.